- 专利标题： NANOEMULSION RESPIRATORY SYNCYTIAL VIRUS (RSV) SUBUNIT VACCINE
-
申请号： EP18192928.2申请日： 2012-09-10
-
公开(公告)号： EP3488863A1公开(公告)日： 2019-05-29
- 发明人: BITKO, Vira , HAMOUDA, Tarek , FATTOM, Ali, I. , BAKER, James, R.
- 申请人： Nanobio Corporation
- 申请人地址： 2311 Green Road, Suite A Ann Arbor, MI 48105 US
- 专利权人： Nanobio Corporation
- 当前专利权人： Nanobio Corporation
- 当前专利权人地址： 2311 Green Road, Suite A Ann Arbor, MI 48105 US
- 代理机构： Herzog, Fiesser & Partner Patentanwälte PartG mbB
- 优先权： US201161533062P 20110909
- 主分类号： A61K39/155
- IPC分类号： A61K39/155 ; A61K47/10 ; A61K47/26 ; A61K47/44 ; A61K47/18 ; A61K9/107 ; A61K39/00 ; A61K39/12
摘要：
The present application relates to the field of immunology, in particular, a vaccine composition of respiratory syncytial virus (RSV) surface proteins, Fusion (F) and Glycoprotein (G) proteins subunit vaccine preferentially mixed with the immune cell targeting and enhancer, nanoemulsion to induce a protective immune response and avoid vaccine-induce disease enhancement.
信息查询
